Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine Infiltration for Postoperative Pain Control After Percutaneous Nephrolithotomy
NCT07721571Recruiting
- Sponsor
- Hitit University
- Start
- Jul 2026
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
Randomised trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (2 arms), sponsored by Hitit University. Primary endpoint: Postoperative Pain Intensity Assessed Using the Visual Analog Scale at 24 hours. Started Jul 2026; status: recruiting.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07721571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07721571.